NASDAQ:LFMD - LifeMD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $10.00
  • Forecasted Upside: 369.48 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$2.13
▲ +0.02 (0.95%)

This chart shows the closing price for LFMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New LifeMD Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LFMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LFMD

Analyst Price Target is $10.00
▲ +369.48% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for LifeMD in the last 3 months. The average price target is $10.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 369.48% upside from the last price of $2.13.

This chart shows the closing price for LFMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in LifeMD.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/18/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2022BTIG ResearchLower Price TargetNA$8.00N/A
5/16/2022B. RileyLower Price Target$16.00 ➝ $8.00High
3/22/2022Colliers SecuritiesReiterated RatingBuyMedium
3/10/2022Colliers SecuritiesInitiated CoverageBuy$14.00High
11/11/2021BTIG ResearchLower Price TargetBuy$30.00 ➝ $15.00High
10/4/2021B. RileyReiterated RatingBuy$16.00Medium
8/13/2021BTIG ResearchLower Price TargetBuy$35.00 ➝ $30.00High
7/19/2021BTIG ResearchLower Price TargetPositive ➝ Buy$43.00 ➝ $35.00Medium
6/8/2021BTIG ResearchReiterated RatingBuy$40.00High
(Data available from 5/19/2017 forward)

News Sentiment Rating

-0.01 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/21/2021
  • 4 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/20/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/20/2021
  • 5 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/19/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/18/2022
  • 1 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/20/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/19/2022
  • 1 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
5/19/2022

Current Sentiment

  • 1 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
LifeMD logo
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Read More

Today's Range

Now: $2.13
Low: $2.04
High: $2.18

50 Day Range

MA: $2.97
Low: $1.91
High: $3.61

52 Week Range

Now: $2.13
Low: $1.85
High: $16.28

Volume

106,143 shs

Average Volume

178,167 shs

Market Capitalization

$65.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Frequently Asked Questions

What sell-side analysts currently cover shares of LifeMD?

The following sell-side analysts have issued reports on LifeMD in the last year: B. Riley, BTIG Research, Colliers Securities, and Zacks Investment Research.
View the latest analyst ratings for LFMD.

What is the current price target for LifeMD?

0 Wall Street analysts have set twelve-month price targets for LifeMD in the last year. Their average twelve-month price target is $10.00, suggesting a possible upside of 369.5%.
View the latest price targets for LFMD.

What is the current consensus analyst rating for LifeMD?

LifeMD currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LFMD will outperform the market and that investors should add to their positions of LifeMD.
View the latest ratings for LFMD.

How do I contact LifeMD's investor relations team?

LifeMD's physical mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company's listed phone number is (866) 351-5907 and its investor relations email address is [email protected] The official website for LifeMD is www.lifemd.com. Learn More about contacing LifeMD investor relations.